Immune Repertoire Sequencing Market Share

North American Market Forecast

The immune repertoire sequencing market in North America is projected to occupy the largest share over the period between 2023 – 2036. This can be ascribed to the high health spending, and strong presence of market players in the region, especially in the United States and Canada. According to the Centers for Medicare & Medicaid Services (CMS), health spending in the United States grew by 9.7% in 2020, reaching a value of USD 4.1 trillion, or USD 12,530 per person. The market is also anticipated to grow with escalating demand for immunotherapy for cancer and other infectious diseases.

APAC Market Statistics

The immune repertoire sequencing market in the Asia Pacific region is estimated to observe noteworthy market demand throughout the estimated period. This can be attributed on the back of the increasing number of international collaborations for immune repertoire sequencing in the region.

In addition, the focus of countries, namely China and Japan, on the integration of new technologies in the healthcare sector is also expected to drive market growth significantly in the coming years.